VESALIUS-CV

Objective

The purpose of this study is to assess the effect of lowering low-density lipoprotein cholesterol (LDL-C) with evolocumab on major cardiovascular events in subjects without a prior MI or stroke at high risk of a cardiovascular event.

View this clinical trail on ClinicalTrials.gov.

Location:

Essentia Health East

Research Study Categories

• Adult Research Studies

Specialties

• Cardiology

Contact

Cardiology Clinical Trials at 866-839-4128, [email protected]